平潭發展(000592.SZ):變更部分募集資金永久性補充流動資金
格隆匯 8 月 19日丨平潭發展(000592.SZ)公佈,公司於2020年8月19日召開了第十屆董事會2020年第二次會議,審議通過了《關於變更部分募集資金永久性補充流動資金的議案》,為提高募集資金使用效率,公司董事會同意變更美麗鄉村(石厝改造)示範區建設項目的募集資金13000萬元及利息,平潭海峽醫療園區建設項目(一期)剩餘的募集資金36411萬元及利息,用於永久性補充流動資金。上述事項獲得了公司獨立董事和監事會同意,保薦機構中信建投證券股份有限公司出具了核查意見,尚需提交公司股東大會審議通過後方可實施。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.